Adults 50+ and those with chronic conditions are more likely to get flu or COVID-19 vaccines—but that protection may not be enough. Talking with a healthcare provider before illness can help ensure timely antiviral use to prevent severe symptoms. Learn more: www.michiganmedicine.org/health-lab/w...

Join CVEEP on 2/13 at 11 AM for a timely conversation on updated COVID-19 guidance and how antivirals can support stronger outbreak response and community readiness. Save your spot: bit.ly/4rv3EC1

Join CVEEP on 2/13 at 11 am for a discussion on the latest COVID-19 guidance and how antiviral use can strengthen outbreak response and community preparedness. Register here: bit.ly/4rv3EC1

Tools like antivirals can help avoid the worst outcomes of illness. Check out our latest webinar where experts lay out what we can do this respiratory season to stay healthy, including making antivirals available to all who need them: bit.ly/4bdjfkV

If you have an underlying condition, respiratory illness can be more severe. Early antiviral treatment helps—but cost remains a barrier. Learn how RAA is addressing access here: respantiviral.org

Confusion shouldn’t be a barrier to care. Yet nearly 11% of high-risk individuals weren’t prescribed antivirals due to uncertainty around eligibility. It’s time to close the gap. Learn more about barriers to treatment here: bit.ly/4smtZDP

Reporting on respiratory illness this season or just interested in learning more? Join the Respiratory Antiviral Alliance + @nationalpress.bsky.social today at noon for a webinar on respiratory antiviral access, new data, and barriers to treatment. Register here: bit.ly/48TOqit.

📣 Don’t miss this free NPF webinar on the 2025–26 respiratory illness season & access to antivirals. 🗓 Dec 16 | 12–1pm ET Hear from experts on respiratory illness trends, antiviral uptake, & uptake barriers on these vital treatments. 🔗 Register: nationalpress.org/training/reg...

Respiratory antivirals save lives — but too many high-risk adults face financial and other barriers to treatment. That’s why we’ve joined the @Respiratory Antiviral Alliance. Learn more:  vist.ly/4gww6 @respantiviral.bsky.social

Today, we’re launching the Respiratory Antiviral Alliance (RAA) — a new coalition dedicated to ensuring older adults and people with chronic conditions can access timely, affordable antiviral treatments for respiratory illnesses. Learn more: bit.ly/4pLq4ht